Immunohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease

American Journal of Gastroenterology

Volumn 94, Issue 12, 1999, Pages 3521-3529

  Bischoff, Stephan C ^a   Mayer, Julika ^a   Nguyen, Quoc Tuong ^a   Stolte, Manfred ^b   Manns, Michael Peter ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; AUTACOID; EOSINOPHIL GRANULE PROTEIN; EOSINOPHIL PROTEIN X; PLASMA PROTEIN; RIBONUCLEASE;

ADULT; ARTICLE; CROHN DISEASE; DISEASE ACTIVITY; EOSINOPHILIC GASTRITIS; FECES ANALYSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; ULCERATIVE COLITIS; AGED; BIOPSY; CECUM; CECUM DISEASE; CHEMISTRY; ENZYME IMMUNOASSAY; EOSINOPHILIA; FECES; GASTROENTERITIS; IMMUNOLOGY; INTESTINE MUCOSA; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BIOPSY; BLOOD PROTEINS; CECAL DISEASES; CECUM; COLITIS, ULCERATIVE; CROHN DISEASE; EOSINOPHIL GRANULE PROTEINS; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILIA; FECES; FEMALE; GASTROENTERITIS; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; RIBONUCLEASES;

EID: 0032589606     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00700-5     Document Type: Article

References (31)

1. Furuta G.T., Ackerman S.J., Wershil B.K. The role of the eosinophil in gastrointestinal diseases. Curr Opin Gastroenterol. 11:1995;541-547.
2. Levy A.M., Kita K. The eosinophil in gut inflammation Effector or director? Gastroenterology. 110:1996;952-954.
3. Gleich G.J., Adolphson C.R., Leiferman K.M. The biology of the eosinophilic leukocyte. Annu Rev Med. 44:1993;85-101.
4. Rothenberg M.E. Eosinophilia. N Engl J Med. 338:1998;1592-1600.
5. Dubucquoi S., Janin A., Klein O., et al. Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut. 37:1995;242-246.
6. Makiyama K., Kanzaki S., Yamasaki K., et al. Activation of eosinophils in the pathophysiology of ulcerative colitis. J Gastroenterol. 30:(suppl 8):1995;64-69.
7. Raab Y., Fredens K., Gerdin B., et al. Eosinophil activation in ulcerative colitis. Dig Dis Sci. 43:1998;1061-1070.
8. Bischoff S.C., Wedemeyer J., Herrmann A., et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology. 28:1996;1-13.
9. Talley N.J., Kephart G.M., McGovern T.W., et al. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology. 103:1992;137-145.
10. Fiocchi C. Inflammatory bowel disease. Etiology and pathogenesis. Gastroenterology. 115:1998;182-205.
11. Naylor A.R. Eosinophilic gastroenteritis. Scott Med J. 35:1990;163-165.
12. Lee C., Changchien C., Chen P., et al. Eosinophilic gastroenteritis. 10 years experience. Am J Gastroenterol. 88:1993;70-74.
13. Blackshaw A.J., Levison D.A. Eosinophilic infiltrates of the gastrointestinal tract. J Clin Pathol. 39:1986;1-7.
14. Torpier G., Colombel J.F., Mathieu-Chandelier C., et al. Eosinophilic gastroenteritis Ultrastructural evidence for a selective release of eosinophil major basic protein . Clin Exp Immunol. 74:1988;404-408.
15. Dvorak A.M. Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo Cytotoxic potential in Crohn's disease . J Immunol. 125:1980;460-462.
16. Bischoff S.C., Grabowsky J., Manns M.P. Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig Dis Sci. 42:1997;394-403.
17. Berstad A., Borkje B., Riedel B., et al. Increased fecal eosinophil cationic protein in inflammatory bowel disease. Hepato-Gastroenterol. 40:1993;276-278.
18. Raab Y., Sundberg C., Hällgren R., et al. Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis. Am J Gastroenterol. 90:1995;615-620.
19. Levy A.M., Gleich G.J., Sandborn W.J., et al. Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease. Mayo Clin Proc. 72:1997;117-123.
20. Tai P.C., Spry C.J., Peterson C., et al. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature. 309:1984;182-184.
21. Jahnsen F.L., Brandtzaeg P., Halstensen T.S. Monoclonal antibody EG2 does not provide reliable immunohistochemical discrimination between resting and activated eosinophils. J Immunol Methods. 175:1994;23-36.
22. Rosenberg H.F., Tiffany H.L. Characterization of the eosinophil granule proteins recognized by the activation-specific antibody EG2. J Leuk Biol. 56:1994;502-506.
23. Hällgren R., Colombel J.F., Dahl R., et al. Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease Studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents . Am J Med. 86:1989;56-64.
24. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of ulcerative colitis. Br Med J. 298:1989;82-86.
25. Beesley J.E. Immunocytochemistry. A practical approach. 1993;Oxford University Press, Oxford.
26. Bischoff S.C., Mayer J., Wedemeyer J., et al. Colonoscopic allergen provocation (COLAP) A new diagnostic approach for gastrointestinal food allergy . Gut. 40:1997;745-753.
27. Synek M., Beasley R., Frew A.J., et al. Cellular infiltration of the airways in asthma of varying severity. Am J Resp Crit Care Med. 154:1996;224-230.
28. Hoshino M., Nakamura Y. Relationship between activated eosinophils of bronchial mucosa and serum eosinophilic cationic protein in atopic asthma. Int Arch Allergy Immunol. 112:1997;59-64.
29. Sont J.K., Han J., van Krieken M, et al. Relationship between inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax. 51:1996;496-502.
30. Desreumaux P., Bloget F., Seguy D., et al. Interleukin 3, granulocyte-macrophage colony stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology. 110:1996;768-774.
31. Colombel J.F., Hällgren R., Venge P., et al. Neutrophil and eosinophil involvement of the small bowel affected by chronic alcoholism. Gut. 29:1988;1656-1660.